Gene editing technique developed in Switzerland shows promise in curing Stargardt disease, a rare genetic eye disease causing ...

Benchmark analysts have increased the price target for Belite Bio, Inc (NASDAQ:BLTE) shares to $79.00, up from the previous ...

Benchmark raised the firm’s price target on Belite Bio (BLTE) to $79 from $57 and keeps a Buy rating on the shares. After speaking to ...

Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, ...

A White Center teenager has been charged with second-degree murder in the death of Roy Steven Bird, 63, who was fatally injured following a violent confrontation near Logan Brewing Company in Burien ...

This is the heart-warming moment a couple discovered they had both planned a surprise proposal for each other on the same day. Sally Morton, 39, had planned to propose to her girlfriend, Leanne ...

Lily-Rae Merchant-O'Hanlon, 12, was diagnosed with Stargardt disease last December. The inherited condition causes blurriness in the central part of the eye and her mother, Emma Merchant ...

A new mega-database of half a million mutations may flag new ways of treating genetic disease, scientists say. When you purchase through links on our site, we may earn an affiliate commission.

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, which often leads to vision loss. Their study shows promising results using a ...